Keyword: World Health Organization
Experts urged the U.S. to allow CDC staff to return to the field, though WHO's director-general insists financial and other support should suffice.
As officials scramble to contain an Ebola outbreak in the Democratic Republic of Congo, the WHO is worried that Merck's vaccine stockpile won't last.
Vaccine trust has fallen in the Philippines since Sanofi's Dengvaxia controversy, and now experts are warning about the threat of measles outbreaks.
Merck kicked off a rolling FDA submission for its Ebola vaccine that's already been deployed against outbreaks in the Democratic Republic of Congo.
Merck's RotaTeq won China approval in April and a launch is underway, but meanwhile, the company is reducing its shipments to low-income countries.
Here is some other vaccine news of note for the week.
GSK touted data for what could be a promising vaccine against tuberculosis, a leading cause of death worldwide.
In what a WHO official described as "high community demand," 4,625 doses of Merck's Ebola vaccine, rVSV-ZEBOV, have been given in the latest outbreak.
China has withheld shipments of the H7N9 strain to the U.S. for research, according to The New York Times.
Initial lab work suggests that the Ebola Zaire strain—the one targeted by Merck's rVSV-ZEBOV—is likely the cause of this outbreak.